A "myriad" of "sizeable" weapons were seized by the police following a stabbing at a Nottingham city centre flat. The ...

SALT LAKE CITY - 专注于分子诊断和精准医疗的Myriad Genetics, Inc. (NASDAQ: MYGN)宣布领导层变动，现任首席运营官Sam Raha将于2025年4月30日起担任总裁兼首席执行官。Raha还将加入董事会，接替即将离任转任私募股权公司Cressey & Company管理合伙人的Paul J. Diaz。Diaz将继续担任Raha ...

周二，摩根大通分析师Rachel Vatnsdal将Myriad Genetics（NASDAQ:MYGN）的目标股价从此前的15.00美元下调至12.00美元，同时维持对该股票的减持评级。此次调整是在Myriad Genetics周一收市后发布第四季度财报之后做出的。

Analysts are pulling back from the Healthcare sector as 2 experts expressed today bearish sentiments on Myriad Genetics (MYGN – Research ...

DASTAN President Farokh Sarmad and CEO Loxley Fernandes took to the stage at Consensus to share their vision for the ...

Gabbi’s telehealth solution provides logistics and educational support to assess breast cancer risk. Patients identified as potentially high risk are connected with a Gabbi clinician to be evaluated ...

Q4 2024 Earnings Call Transcript February 24, 2025 Operator: Good day, and thank you for standing by. Welcome to the Myriad ...

SALT LAKE CITY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced a collaboration with Gabbi ...

Myriad Genetics Chief Executive Paul J. Diaz will leave the company April 30 to return to private equity firm Cressey & Co., where he will be a managing partner. The former Kindred Healthcare CEO was ...